Journal List > Allergy Asthma Respir Dis > v.4(3) > 1059186

Lee, Kang, Jung, Jang, Lee, Ahn, Min, and Korean Academy of Asthma, Allergy and Clinical Immunology Anaphylaxis Work Group: ERRATUM: Correction of explanation for footnote in Table 3. Clinical experience in managing patients with hereditary angioedema in Korea: questionnaire survey and a literature review
Allergy Asthma Respir Dis 2014;2(4):277-284
*Only Cinryze is approved for maintenance treatment by Food and Drug Administration. Bradykinin B2 receptor antagonist. Kallikrein inhibitor.
Similar articles